Prevalence and prognostic value of significant mitral regurgitation development after pacemaker implantation

Back

ESC Professional Premium Access

Prevalence and prognostic value of significant mitral regurgitation development after pacemaker implantation

Session: Mechanisms and outcomes in valvular heart disease

Topic: Mitral Valve Regurgitation

Speaker: Doctor T. Nabeta (Sagamihara, JP)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Takeru Nabeta

Kitasato University School of Medicine, Sagamihara (Japan)

0 follower

7 more presentations in this session

Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes

Speaker: Doctor S. Ratwatte (Sydney, AU)

Association of aortic valve size with the degree of aortic valve calcification in patients with severe aortic stenosis

Speaker: Miss R. Mousavi (St Poelten, AT)

Sex influence in the etiology and long-term prognosis of significant tricuspid regurgitation

Speaker: Doctor G. Alegre Garcia (Malaga, ES)

Mitral annular calcification in patients with severe aortic stenosis underwent transcatheter aortic valve implantation: prevalence and association with stenosis severity

Speaker: Miss A. Wicheantawatchai (Bangkok, TH)

Arrhythmic form of mitral valve prolapse: presentation, risk stratification and management

Speaker: Doctor Y. Elgharably (Cairo, EG)

Access

Abstract

Slides

Access the full session

Mechanisms and outcomes in valvular heart disease

Speakers: Doctor T. Nabeta, Doctor S. Ratwatte, Miss R. Mousavi, Doctor G. Alegre Garcia, Miss A. Wicheantawatchai...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources